LONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
The race to develop powerful new weight-loss drugs grew even more heated on Thursday as Roche Holding AG released early-stage trial results for an experimental obesity treatment. The once-weekly ...
In 1943 Vincent Speranza, the son of Italian immigrants, enlisted when he turned 18. "I decided to be a paratrooper when I found out that that would probably be the fastest way to get into the ...
Roche ROG1.18%increase; green up pointing triangle Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
, opens new tab shares gained as much as 4.7% on Thursday after an early-stage trial showed that a newly-acquired obesity drug candidate led to significant weight loss, a key step in Swiss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results